Catalysts for GlaxoSmithKline LLC
412 tracked
Mar 27, 2026
approval
ZEJULA (NIRAPARIB TOSYLATE) โ FDA approval
niraparib
โ
Mar 23, 2026
approval
MALARONE PEDIATRIC (ATOVAQUONE) โ FDA approval
atovaquone
โ
Mar 20, 2026
approval
MEPRON (ATOVAQUONE) โ FDA approval
atovaquone
โ
Mar 18, 2026
approval
OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) โ FDA approval
momelotinib dihydrochloride
โ
Mar 18, 2026
approval
OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) โ FDA approval
momelotinib dihydrochloride
โ
Mar 17, 2026
approval
LYNAVOY (LINERIXIBAT) โ FDA approval
linerixibat
โ
Mar 9, 2026
approval
WELLCOVORIN (LEUCOVORIN CALCIUM) โ FDA approval
LEUCOVORIN CALCIUM
โ
Jan 21, 2026
recall
GOLD STAR DISTRIBUTION INC recall (Cls II)
GlaxoSmithKline LLC
โ
Jan 21, 2026
recall
GOLD STAR DISTRIBUTION INC recall (Cls II)
GlaxoSmithKline LLC
โ
Dec 19, 2025
approval
FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) โ FDA approval
GlaxoSmithKline LLC
โ
Dec 16, 2025
approval
EXDENSUR (DEPEMOKIMAB-ULAA) โ FDA approval
depemokimab
โ
Dec 11, 2025
approval
BLUJEPA (GEPOTIDACIN MESYLATE) โ FDA approval
gepotidacin mesylate
โ
Dec 9, 2025
approval
IMITREX (SUMATRIPTAN SUCCINATE) โ FDA approval
SUMATRIPTAN SUCCINATE
โ
Dec 9, 2025
approval
IMITREX (SUMATRIPTAN) โ FDA approval
SUMATRIPTAN SUCCINATE
โ
Dec 9, 2025
approval
IMITREX STATDOSE (SUMATRIPTAN SUCCINATE) โ FDA approval
SUMATRIPTAN SUCCINATE
โ
Dec 1, 2025
approval
ALBUTEROL SULFATE โ FDA approval
GlaxoSmithKline LLC
โ
Nov 12, 2025
approval
VALTREX (VALACYCLOVIR HYDROCHLORIDE) โ FDA approval
VALACYCLOVIR HYDROCHLORIDE
โ
Nov 5, 2025
approval
WELLBUTRIN (BUPROPION HYDROCHLORIDE) โ FDA approval
BUPROPION HYDROCHLORIDE
โ
Nov 5, 2025
approval
WELLBUTRIN SR (BUPROPION HYDROCHLORIDE) โ FDA approval
BUPROPION HYDROCHLORIDE
โ
Nov 3, 2025
approval
BREXAFEMME (IBREXAFUNGERP CITRATE) โ FDA approval
ibrexafungerp citrate
โ
Oct 23, 2025
approval
BLENREP (BELANTAMAB MAFODOTIN-BLMF) โ FDA approval
belantamab mafodotin
โ
Oct 10, 2025
approval
LAMICTAL XR (LAMOTRIGINE) โ FDA approval
LAMOTRIGINE
โ
Oct 10, 2025
approval
LAMICTAL XR (LAMOTRIGINE) โ FDA approval
LAMOTRIGINE
โ
Oct 10, 2025
approval
LAMICTAL CD (LAMOTRIGINE) โ FDA approval
LAMOTRIGINE
โ
Oct 10, 2025
approval
LAMICTAL CD (LAMOTRIGINE) โ FDA approval
LAMOTRIGINE
โ
Oct 10, 2025
approval
LAMICTAL (LAMOTRIGINE) โ FDA approval
LAMOTRIGINE
โ
Oct 10, 2025
approval
LAMICTAL (LAMOTRIGINE) โ FDA approval
LAMOTRIGINE
โ
Oct 10, 2025
approval
LAMICTAL ODT (LAMOTRIGINE) โ FDA approval
LAMOTRIGINE
โ
Oct 10, 2025
approval
LAMICTAL ODT (LAMOTRIGINE) โ FDA approval
LAMOTRIGINE
โ
Sep 15, 2025
approval
FLONASE SENSIMIST ALLERGY RELIEF (FLUTICASONE FUROATE) โ FDA approval
GlaxoSmithKline LLC
โ